203 related articles for article (PubMed ID: 15451533)
1. Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs.
Tiemessen H; van Hoogevest P; Leigh ML
Eur J Pharm Biopharm; 2004 Nov; 58(3):587-93. PubMed ID: 15451533
[TBL] [Abstract][Full Text] [Related]
2. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
Hu L; Tang X; Cui F
J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
[TBL] [Abstract][Full Text] [Related]
4. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
Cole ET; Cadé D; Benameur H
Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
[TBL] [Abstract][Full Text] [Related]
5. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.
Kanzer J; Tho I; Flaten GE; Mägerlein M; Hölig P; Fricker G; Brandl M
J Pharm Pharmacol; 2010 Nov; 62(11):1591-8. PubMed ID: 21039543
[TBL] [Abstract][Full Text] [Related]
6. Role of in vitro release models in formulation development and quality control of parenteral depots.
Larsen C; Larsen SW; Jensen H; Yaghmur A; Ostergaard J
Expert Opin Drug Deliv; 2009 Dec; 6(12):1283-95. PubMed ID: 19941410
[TBL] [Abstract][Full Text] [Related]
7. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
8. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
Fahr A; van Hoogevest P; May S; Bergstrand N; S Leigh ML
Eur J Pharm Sci; 2005 Nov; 26(3-4):251-65. PubMed ID: 16112849
[TBL] [Abstract][Full Text] [Related]
9. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
Vasconcelos T; Sarmento B; Costa P
Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
[TBL] [Abstract][Full Text] [Related]
10. Instant solubilization of poorly water-soluble drugs by in-situ loading of aqueous phospholipid dispersions suitable for parenteral administration.
Van Hoogevest P; Rogue V; Brumec M; Schwebel H; Grunkemeyer JL; Leigh ML
PDA J Pharm Sci Technol; 2006; 60(6):366-77. PubMed ID: 17260902
[TBL] [Abstract][Full Text] [Related]
11. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
[TBL] [Abstract][Full Text] [Related]
12. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
13. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in intravenous delivery of poorly water-soluble compounds.
Shi Y; Porter W; Merdan T; Li LC
Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
[TBL] [Abstract][Full Text] [Related]
15. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
O'Driscoll CM; Griffin BT
Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
[TBL] [Abstract][Full Text] [Related]
16. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
Constantinides PP; Chaubal MV; Shorr R
Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
[TBL] [Abstract][Full Text] [Related]
17. Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique.
Douroumis D; Fahr A
Eur J Pharm Biopharm; 2006 Jun; 63(2):173-5. PubMed ID: 16621482
[TBL] [Abstract][Full Text] [Related]
18. Lipid-based systems for the enhanced delivery of poorly water soluble drugs.
Porter CJ; Wasan KM; Constantinides P
Adv Drug Deliv Rev; 2008 Mar; 60(6):615-6. PubMed ID: 18160174
[No Abstract] [Full Text] [Related]
19. Drug release from liquisolid systems: speed it up, slow it down.
Nokhodchi A; Hentzschel CM; Leopold CS
Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrins in drug delivery.
Loftsson T; Jarho P; Másson M; Järvinen T
Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]